These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36997471)

  • 1. Public health detailing to increase naloxone access in NYC pharmacies.
    Foster CL; Tuazon E; Winkelstein E; Kunins HV; Kattan JA
    J Am Pharm Assoc (2003); 2023; 63(3):885-892. PubMed ID: 36997471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.
    Slocum S; Ozga JE; Joyce R; Walley AY; Pollini RA
    BMC Public Health; 2022 Apr; 22(1):735. PubMed ID: 35418048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Like it was just everyday business": A qualitative study of pharmacy-based naloxone and syringe customer experience.
    Gray M; Shin SS; Silcox J; Flores D; Bolivar D; Irwin AN; Floyd AS; Bratberg J; Boggis JS; Hartung DM; Green TC
    J Am Pharm Assoc (2003); 2023; 63(3):838-846. PubMed ID: 36872182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of opioid overdose education and naloxone distribution in New York City.
    Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
    Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.
    Skoy E; Werremeyer A; Steig J; Eukel H; Frenzel O; Strand M
    Subst Abus; 2021; 42(4):672-677. PubMed ID: 33044896
    [No Abstract]   [Full Text] [Related]  

  • 7. Time for Pharmacy Co-dispensing of Naloxone with Prescribed Opioids?
    Wunderlich JR; Engelberg RS; Tofighi B; Schwartz MD
    J Gen Intern Med; 2022 Aug; 37(11):2621-2623. PubMed ID: 35581455
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of Pharmacy Student Interns into a Naloxone Telephone Outreach Service.
    Rothbauer K; Genisot A; Frey T; JohnsonPharmacy William S Middleton Memorial Veterans Hospital D
    J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):208-215. PubMed ID: 35997489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.
    Zaller ND; Yokell MA; Green TC; Gaggin J; Case P
    Subst Use Misuse; 2013 Jun; 48(8):590-9. PubMed ID: 23750660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas.
    Evoy KE; Groff L; Hill LG; Godinez W; Gandhi R; Reveles KR
    J Am Pharm Assoc (2003); 2020; 60(1):81-86. PubMed ID: 31669417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process.
    Grant S; Smart R
    Harm Reduct J; 2022 Jun; 19(1):64. PubMed ID: 35676719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of Naloxone in 2 Underserved Urban Communities in Georgia.
    Saraiya P; Hutchins SS; Crump S; Morgan J; Wilkinson T; Walker CD; Taylor B
    J Public Health Manag Pract; 2021 May-Jun 01; 27(Suppl 3):S179-S185. PubMed ID: 33785693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.